Bank Of New York Mellon Corp Halozyme Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$32.86 - $55.7 $45.7 Million - $77.4 Million	1,389,671 New	1,389,671 $53.1 Billion
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $57.6 Million - $85.5 Million	1,438,370 New	1,438,370 $81.8 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $731,530 - $983,095	-18,986 Reduced 1.23%	1,521,290 $60.2 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $446,818 - $577,812	11,963 Added 0.78%	1,540,276 $67.8 Million
Q1 2022 May 11, 2022	SELL	$31.97 - $41.06 $382,137 - $490,790	-11,953 Reduced 0.78%	1,528,313 $61 Million
Q4 2021 Feb 11, 2022	SELL	$31.82 - $40.75 $962,841 - $1.23 Million	-30,259 Reduced 1.93%	1,540,266 $61.9 Million
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $3.54 Million - $4.27 Million	92,038 Added 6.23%	1,570,525 $63.9 Million
Q2 2021 Aug 11, 2021	BUY	$38.84 - $51.31 $1.34 Million - $1.77 Million	34,490 Added 2.39%	1,478,487 $67.1 Million
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $1.11 Million - $1.45 Million	-28,115 Reduced 1.91%	1,443,997 $60.2 Million
Q4 2020 Feb 09, 2021	BUY	$25.81 - $43.62 $19.4 Million - $32.8 Million	753,065 Added 104.73%	1,472,112 $62.9 Million
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $587,875 - $676,719	22,839 Added 3.28%	719,047 $18.9 Million
Q2 2020 Aug 12, 2020	BUY	$16.25 - $26.81 $1.19 Million - $1.97 Million	73,316 Added 11.77%	696,208 $18.7 Million
Q1 2020 May 06, 2020	SELL	$13.9 - $21.83 $303,145 - $476,090	-21,809 Reduced 3.38%	622,892 $11.2 Million
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $18,423 - $24,100	1,234 Added 0.19%	644,701 $11.4 Million
Q3 2019 Nov 07, 2019	SELL	$15.2 - $17.69 $265,042 - $308,460	-17,437 Reduced 2.64%	643,467 $9.98 Million
Q2 2019 Aug 12, 2019	BUY	$14.75 - $17.26 $276,370 - $323,400	18,737 Added 2.92%	660,904 $11.4 Million
Q1 2019 May 14, 2019	SELL	$13.94 - $17.58 $274,841 - $346,607	-19,716 Reduced 2.98%	642,167 $10.3 Million
Q4 2018 Feb 11, 2019	SELL	$13.33 - $18.66 $13.8 Million - $19.3 Million	-1,032,894 Reduced 60.95%	661,883 $9.68 Million
Q3 2018 Nov 09, 2018	SELL	$16.68 - $18.41 $192,503 - $212,469	-11,541 Reduced 0.68%	1,694,777 $0
Q2 2018 Aug 06, 2018	SELL	$16.87 - $20.3 $145,790 - $175,432	-8,642 Reduced 0.5%	1,706,318 $28.8 Million
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $2.43 Million - $3.01 Million	-142,154 Reduced 7.65%	1,714,960 $33.6 Million
Q4 2017 Feb 09, 2018	BUY	$16.75 - $20.8 $31.1 Million - $38.6 Million	1,857,114	1,857,114 $37.6 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account